KAINOS MEDICINE, INC. Logo

KAINOS MEDICINE, INC.

Develops small molecule therapeutics for neurodegenerative, infectious, and oncological diseases.

284620 | KO

Overview

Corporate Details

ISIN(s):
KR7284620002
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 700 코리아바이오파크 제3층 제에이-301호 일부, 성남시

Description

Kainos Medicine, Inc. is a clinical-stage research and development company specializing in the discovery of novel small molecule therapeutics. The company's primary focus is on addressing unmet medical needs in neurodegenerative disorders, infectious diseases, and oncology. Its drug pipeline includes candidates for the treatment of conditions such as Parkinson's disease, Multiple System Atrophy (MSA), AIDS, and various cancers. Kainos Medicine is dedicated to developing innovative treatments for these challenging diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2022-09-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 32.6 KB
2022-09-21 00:00
[기재정정]전환사채(해외전환사채포함)발행후만기전사채취득(제2회차)
Korean 15.9 KB
2022-09-20 00:00
전환사채(해외전환사채포함)발행후만기전사채취득(제2회차)
Korean 11.1 KB
2022-09-16 00:00
증권발행결과(자율공시)(주주배정 유상증자)
Korean 8.2 KB
2022-09-16 00:00
증권발행실적보고서
Korean 92.6 KB
2022-09-16 00:00
[기재정정]증권발행실적보고서
Korean 117.9 KB
2022-09-15 00:00
유상증자또는주식관련사채등의청약결과(자율공시)(주주배정 유상증자)
Korean 10.6 KB
2022-09-07 00:00
유상증자또는주식관련사채등의청약결과(자율공시)(주주배정 유상증자)
Korean 8.7 KB
2022-09-06 00:00
주식등의대량보유상황보고서(일반)
Korean 200.5 KB
2022-09-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 43.2 KB
2022-09-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 38.2 KB
2022-09-01 00:00
유상증자최종발행가액확정
Korean 11.3 KB
2022-09-01 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 34.8 KB
2022-09-01 00:00
[발행조건확정]증권신고서(지분증권)
Korean 162.1 KB

Automate Your Workflow. Get a real-time feed of all KAINOS MEDICINE, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAINOS MEDICINE, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAINOS MEDICINE, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.